FMCQF News and Press, Fresenius Med Care Ag Ord From 10/29/20

The following slide deck was published by Fresenius Medical Care AG & Co. KGaA in conjunction with their 2020 Q3 earnings call. For further details see: Fresenius Medical Care AG & Co. KGaA 2020 Q3 - Results - Earnings Call Presentation

Following several pre-COVID guidance cuts, Fresenius had lost investors' faith. The pandemic, while certainly not a positive for a hospital operator, has not produced any fundamental deterioration of the business. COVID-19 has also masked an underlying improvement of Fresenius' He...

The earnings season came to a close and markets were mostly flat. I am continuing my monthly investment plans and suspiciously follow the massive rally in technology stocks. Whether it is a bubble or not, I won't stop investing. My dividend income from 37 corporations amounted...

Quick Take Outset Medical ( OM ) has filed to raise $175 million from the sale of its common stock in an IPO, according to an amended registration statement . The company has developed an improved kidney dialysis device for institutional and home use. OM is growing quickly from a low ba...

As a whole set of factors should be negatively impacting markets, such as the ongoing pandemic, an uncertain path to economic recovery and the even more uncertain November U.S. Presidential Elections, markets are shaking off these concerns and racing to new highs almost every single day in Aug...

Investment Thesis Baxter International's (BAX) global presence signals fundamental strength, albeit with a bumpy Q2 exit, missing the Street's estimates on revenue by -4%, net income by -21% and EPS by $0.07. BAX has comparative advantages relative to peers within the medical devices and ins...

Quick Take Outset Medical ( OM ) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement . The firm has developed a patented hemodialysis machine for patients with reduced kidney function. OM looks well positioned to provide a differenti...

Quick Take PainReform ( PRFX ) intends to raise $23 million from the sale of its common stock in an IPO, according to an amended registration statement . The company is developing a reformulated pain relief medication for post-operative pain reduction. PRFX management has performed well...

Fresenius Medical Care AG & Co. KGaA (FMS) Q2 2020 Earnings Conference Call July 30, 2020, 09:30 ET Company Participants Dominik Heger - EVP & Head, IR, Strategic Development & Communications Robert Powell - Chairman & CEO Helen Giza - CFO Conference Call Parti...

The following slide deck was published by Fresenius Medical Care AG & Co. KGaA in conjunction with their 2020 Q2 earnings Read more ...